Cardiac Biomarker Testing Market Anticipated to Reach $18,232 million by 2026

The Global Cardiac Biomarker Testing Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

The global Cardiac Biomarker Testing Market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%.

Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart.

Get sample for this report @

The global cardiac biomarker testing market is segmented based on type, application, location of testing, and region. By type, the market is fragmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA), and others. Depending on application, it is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, it is bifurcated into point of care testing and laboratory testing. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


  • This report highlights the market dynamics to understand the global cardiac biomarker testing market and capitalize on the prevailing opportunities.
  • Quantitative analysis of the current market and forecasts assists stakeholders to design business strategies accordingly.
  • Porter\’s five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
  • Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.


  • By Type 
  1. Myocardial Muscle Creatine Kinase (CK-MB)
  2. Troponins (T and I)
  3. Myoglobin
  4. Brain Natriuretic Peptide (BNPs) or NT-proBNP
  5. Ischemia-modified Albumin (IMA)
  • By Application 
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Atherosclerosis
  • By Location of Testing
  1. Point of Care Testing
  2. Laboratory Testing

By Region

North America

  • U.S.
  • Canada
  • Mexico


  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe


  • Australia
  • Japan
  • India
  • China
  • Rest of Asia-Pacific


  1. Latin America
  2. Middle East
  3. Africa


  1. Roche Diagnostics
  2. Abbott Laboratories
  3. Siemens Healthcare
  4. Becton, Dickinson and Company
  5. Bio-Rad Laboratories
  6. BioMerieux
  7. PerkinElmer Inc.
  8. Tosoh Corporation
  9. Danaher Corporation
  10. Thermo Fisher Scientific

The other players in the value chain include (profiles not included in the report):

  1. Randox Laboratories
  2. Johnson and Johnson
  3. Olympus Corporation
  4. BG Medicines
  5. ACS Biomarker B.V.
  6. Cavadis Biomedical.

Get purchase discount @

About Us:

Big Market Research has a range of research reports of various domains across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

Contact Us:

Mr. Abhishek Paliwal

Big Market Research

5933 NE Win Sivers Drive, #205, Portland,

OR 97220 United States

Direct: +1-971-202-1575

Toll Free: +1-800-910-6452





Jennifer Bradshaw

Jennifer is one of the founders of Market Research Analyst. She handles the editorial tasks and is helped by a team of contributors. Jennifer has over 10 years of experience in news industry in general and 5 years of experience in the online new world.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *